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1. Introduction
The greatest prophylaxis challenge in dentistry is the control of dental biofilm and conse‐
quently, avoiding dental caries and gingival inflammation [1]. This control is generally car‐
ried out through mechanical and ⁄ or chemical methods. Although the mechanical methods
(toothbrush and dental floss) are considered efficient, they are not sufficiently so in certain
cases [2], [3].
Individuals with Down syndrome (DS) present various oral diseases, such as the presence of
pseudoprognatismo, hard palate and lower ogival shape; pseudomacroglossia due to hypo‐
tonia tongue; high prevalence and susceptibility to periodontal problems due to error in the
autoregulatory mechanism immune, and poor occlusal relationship, with a predominance of
anterior crossbite and / or later. The position of the tongue protruded, produces abnormal
strength in the lower anterior teeth, which normally are in a position to cross-bite. These fac‐
tors favor the onset of severe periodontitis, leading to early loss of teeth. However, there is a
lower incidence of dental caries, which has been attributed mainly to the increase in buffer
capacity of saliva [4].
Some dental anomalies can be observed, as the presence of hypodontia or oligodontia, tooth
conoids, microteeth, hypocalcification enamel, fusion and twinning can also be an increase
in the size of the clinical crown of molars and the inclination of the occlusal surface to the
lingual, making access to restorative procedures. Furthermore, the rash and exfoliation of
the primary teeth and eruption of the permanent are delayed, and there is a high prevalence
of bruxism [4], and these alterations interfere with the quality of toothbrushing.
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Figure 1. Pseudomacroglossia due to hypotonia tongue
There is agreement among many authors on the existence of factors predisposing to perio‐
dontal disease in patients with Down syndrome. Although poor oral hygiene, poor nutrition
and local irritants may exacerbate this problem, they can not be regarded as its main cause.
The greater predisposition to periodontal disease has been attributed to characteristics of pa‐
tients with chromosomal abnormalities of trisomy [5].It is therefore essential to establish
strategies to p revent periodontal disease in these individuals.
Second Cornejo et al. [6] (1996), which conducted a study in 86 individuals with DS living in
Argentina, aged between 3 and 19 years, the presence of the changes described above puts
them at a disadvantage in relation to oral health, compared with noncarriers.
Besides the inherent disadvantage to the individual, access to dental care is also difficult for
these people. Allison et al. [7] (2000), in a study conducted in France, compared the levels of
care received dental services and oral hygiene habits among children with DS and their sib‐
lings. According to parents and / or guardians, the group with DS had difficulty finding ac‐
cess to dental services and oral care compared to their phenotypically normal siblings. In
Brazil, studying the prevalence of dental caries in primary and permanent teeth of children
with DS in Sao Jose dos Campos (SP), Moraes et al. [8] (2002) found that the values of ceo
and CPO-D were similar to those identified by the Municipal Health Department, in a sur‐
vey of dental caries in children from public schools. However, the authors found a frequen‐
cy of 9.25% and 4.76% decayed teeth restored among the children examined, against the
values of 3.98% and 5.88%, respectively, obtained by the Municipal Health.
All these mentioned aspects can be inferred that it would be essential to adopt appropriate
measures aimed at controlling biofilm among the DS patients, to prevent the installation of
dental caries and gingival inflammation, because the microorganisms in the biofilm and act
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decisively etiologic agents in the origin and development of caries and periodontal also (Kö‐
nig et al. [9] 2002). In 1965, Löe et al. [10] demonstrated the direct relationship between the
biofilm and the development of gingivitis in humans, concluding that the removal of biofilm
employing brushing and flossing, could result in reversal in health (Löe et al. [10] 1965,
Theilade et al. [11] 1966). For this reason, control of the biofilm has an important role in the
prevention, treatment and maintenance of periodontal health.
2. Mechanical control of dental biofilm
The mechanical control is to remove biofilm employing proper technique of brushing, com‐
bined with a dentifrice and auxiliary materials such as wire or dental tape (Owens et al. [12]
1997).
The ability to remove dental biofilm by the use of different types of brushes is basically the
same. There is no ideal brush, and your choice should be guided by the needs of each indi‐
vidual patient and clinical observations of the professional. However, there are characteris‐
tics that facilitate the oral hygiene procedures, as the presence of small head multitufuladas,
soft bristle, rounded second study by Panzeri et al. [13] (1993).
The toothbrushing is an effective procedure for the maintenance of proper oral hygiene.
However, to get a good cleaning of the oral cavity, in addition to toothbrushes, other factors
must be considered such as time, frequency, brushing technique, manual skills and motiva‐
tion of patients (Halla [14] 1982).
 
Figure 2. Motivation of patients and toothbrushing
Several authors report that, although brushing is the most widespread and universally suit‐
able for the mechanical removal of the plate are not known techniques ideal nor brushes
which, by itself, may promote a perfect cleaning. All this technical device should be associat‐
ed with constant motivation [12],[15]-[16].
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 Figure 3. Toothbrushing technique and manual skills
The control of dental biofilm is a preventive action that involves a number of aspects, such
as health education, which is achieved through constant guidance and motivation for people
on oral hygiene (Bijella [17]1999).
The manual dexterity and, many times, the motivation, are indispensable factors for efficient
oral hygiene through mechanical means in patients with Down syndrome [18]-[22]. Thus,
the key to success in promoting and maintaining a satisfactory oral health in these patients
is the application of a rigorous program of oral hygiene constant [23].
 
Figure 4. Lecture to motivate the control of biofilm
Mental disability is another aspect to be considered as difficult to awareness of the impor‐
tance of oral health, difficulty in learning the techniques of brushing and lack of concentra‐
tion at the time of toothbrushing [24],[25]. This difficulty leads these patients to have high
levels of plaque-dependent oral diseases, especially periodontal changes 6. It is therefore es‐
sential to establish strategies to prevent periodontal disease in these individuals.
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 Figure 5. Constant guidance and motivation
Second Nielsen [26] (1990), the type and degree of disability are also important factors, since
the greater the degree of mental deficiency the worse the level of hygiene.
3. Dentifrices with disclosing agent dental biofilm
The obstacles inherent to children with Down syndrome and the difficulties faced by pa‐
rents and ⁄ or people in charge for toothbrushing, lead the professional in dentistry to look
for a substance capable of aiding and stimulating these patients in the mechanical control of
the dental biofilm. Studies suggest the use of disclosing agents, such as erythrosine, to re‐
move dental biofilm more easily. For this reason, the presence of a disclosing agent in the
formulation of the dentifrice could aid in the removal of the dental biofilm [27].
Are disclosing the chemicals used for staining bacteria, which show the colonies, invisible or
barely visible, that adhere to tooth surfaces, making them visible, thus supporting the main‐
tenance of oral hygiene while facilitating their removal (Bellini et al. [27]1974). Among the
forms of application of disclosing the most commonly used in dentistry are tablets or solu‐
tions (Medeiros [28]1991).
The proven merit of disclosing meant that its use became a source of motivation (Toassi, Pet‐
ry [29]2002), are indicated as excellent aids in determining the state of oral hygiene. Shown
to be valuable as a teaching tool in education, not only by convincing the population for the
presence of dental biofilm, as well as raising awareness about the need for its removal (Cris‐
tiano, Bignelli [30]1995).
Second Bouquet [31] (1971) and Gillings [32] (1977), the disclosing must provide ease of ap‐
plication and handling, good flavor, not blushing residually plastic restorations or tooth
cracks, do not stain the mucosal lip, cheek and gum, to be of contrasting color facilitate the
differentiation from the marginal gingiva and does not cause tissue irritation.
There are a variety of disclosing the market, among them are methylene blue, eosin, erythro‐
sin, fluorescein sodium, neutral red and proflavine monosulfate. According to the work of
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Silva et al. [33] (2002), among all the solutions mentioned, eosin, erythrosine and neutral red
showed the greatest ability to blush, ease of removal and absence of antimicrobial activity,
are essential requirements in studies evaluating methods of hygiene and guidance patient.
Erythrosine a dye consisting of the disodium salt of 3 ', 6' - dihydroxy - 2 ', 4', 5 ', 7' - tetraio‐
dospiro [isobenzenofurano -1 (3H), 9 - [9H] xateno] - 3 - one and may contain up to 4.0%
Fluoresceins a lesser degree of iodination, and chloride and / or sodium sulfate and water of
crystallization. Must contain at least 85% calculated as total dye C20H6I4O5Na2. Presented as
physical characteristics: fine powder, red or brown odorless, soluble in water and hidroscó‐
pio giving red solution should not exhibit fluorescent room light, also soluble in ethanol,
glycerin and propylene glycol. Practically insoluble in ether, mineral oil and fats (Standing
Committee Review of the Brazilian Pharmacopoeia [34] 1996).
Figure 6. Structural formula erythrosine
The use of a dentifrice containing the color erythrosine as agent for removal of dental bio‐
film during toothbrushing is an excellent resource to stimulate the patient in your dental hy‐
giene (Quintanilla, Bastos [35]1988), because the presence of this dye to facilitate parents and
individuals / or guardians to view the plaque, especially in places where there is greater dif‐
ficulty of removal during brushing (Duarte et al. [36]1990).
The use of toothpaste containing erythrosine, Dentplaque ®, was approved by the ADA,
and is used as part of a program to promote oral health, being distributed by the Ministry of
Health in 1999, the Health Secretariat of São Paul, including the Regional Health of Piracica‐
ba, Piracicaba encompassing than 25 cities in the region (Silva et al. [37] 2004).
According to research Quintanilla et al. [38] (1989) where they studied the clinical behavior
of the dentifrice added erythrosine Dentplaque ® 0.5% by comparing the new proposal to
existing, as the common dentifrice and dental plaque disclosing in tablet form coadjuntor
dentifrice common comparing the percentage of plaque remaining and the time taken to
perform each of the three proposals in nine females with mean age of 21.33 years, and all
with private have never experienced the use of a plaque disclosing. Individuals selected for
the sample received no instruction on brushing technique, since the aim was to assess
whether humans would be able to remove plaque evident on the surfaces of the teeth, ac‐
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cording to the manual skills of each participant. The time was recorded in seconds since the
beginning of each experiment (opening the packages), to its end. To evaluate the remaining
plate, disclosure was made with basic fuchsin after each experiment, and recorded the num‐
ber of stained surfaces, indicating the remaining plaque. The authors found that the average
time of tooth brushing with toothpaste containing erythrosine has become more than double
when compared to an ordinary toothpaste. Regarding the plaque index, the authors ob‐
served that the impregnation of the dye this is most efficient method III (Dentplaque ®), be‐
cause the dye is rubbed on the plaque while toothbrushing, when compared to other (MI -
toothbrushing with dentifrice common; M II - use of disclosing tablets plaque and
toothbrushing with dentifrice common).
However, Rodrigues et al. [39] (1994) found different result. Undertook a study on the effec‐
tiveness of the dentifrices containing erythrosine Dentplaque ® in the stimulation process to
dental hygiene for 45 male children, aged 6-12 years living in an orphanage in the city of Rio
de Janeiro. These children were divided randomly into three groups of 15 patients main‐
tained the same dietary habits. Initially, all received instructions on oral hygiene and tooth‐
brushing technique, through lectures and posters illustrative devices. Were given tuition
every 30 days during the 90 days of the survey. The brushing technique recommended in
this study was to headphones, and recommended its implementation soon after meals. The
control group made use of the brush with your regular dentifrice, the second group made
use of a disclosing in tablet form before each brushing, and use your usual toothpaste, and
the third group used a dentifrice containing erythrosine for toothbrushing routine. These
children were supervised daily by an official of the orphanage properly oriented. In the ini‐
tial evaluation, all were subjected to three more evaluations, with a 30-day interval between
them being given the simplified oral hygiene index of Greene & Vermillion. The authors
concluded that there were no statistical differences in relation to reducing the level of dental
plaque in the three groups, but it was observed that the dentifrice was the easiest way of
disclosure, and inserts a method of assimilation more difficult for children aged 6-12 years.
The same result of the work of Rodrigues et al. [39] (1994) found in Silva et al. [97] (2004),
with 62 students at a public school in the city of Piracicaba, aged between 12 and 14 years.
Participants were divided into groups: dentifrice with erythrosine Dentplaque ® (Group I)
and the use of disclosing tablets (Group II). The plaque reduction was observed in all
groups did not show statistically significant differences between them. However, the au‐
thors noted that factors that had limited the completion of this study, as the amount of sam‐
ple, the low amount of plaque revealed by the index and the small amount of plaque shown
by the students may have influenced the results, covering the response of the methods. In
addition, the fact that some individuals participated in this study only the initial assessment,
refusing to participate in the final evaluation, the amount of the sample was reduced to 18
participants.
In this context, the use of a dentifrice with erythrosine, as an agent for plaque removal
should encourage the completion of a thorough toothbrushing, presumably more closely in‐
dividual (Silva et al. [40] 2003).
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4. Chemical control of dental biofilm
Studies have shown that mechanical control produces significant reductions in gingivitis in
people with special needs. However, many patients with Down syndrome, besides being
unable to cooperate, do not have sufficient manual dexterity to do toothbrushing or to use
dental floss. Consequently, the use of chemical and ⁄ or antimicrobial agents as aids in pla‐
que control can be indicated for these individuals. Considering the fact that toothbrushing
with dentifrice is the most common tool for good oral hygiene, adding chlorhexidine to den‐
tifrices could be seen as a practical means of improving the quality of oral hygiene [2, 41-47].
The chemicals and / or antimicrobial agents are often used in dental plaque reduction and
can be used in conjunction with the mechanical control in preserving health and treatment
of gingivitis, in some patients (Mandel [48] 1994), especially those that have little manual
dexterity to the realization of toothbrushing (Fischman [49] 1979).
The attributes required for a chemical agent can play its effectiveness in controlling supra‐
gingival biofilm was postulated by Loesche [50] (1976). According to the author, the chemi‐
cal agent to be effective against microorganisms responsible for inflammation and must
have substantivity, ie, the intraoral retention capacity, to achieve a contact time sufficient to
act on the microorganisms existing, and to maintain inhibition dental biofilm formation by a
longer period. Furthermore, the product must be stable at room temperature for a consider‐
able time and safe for human use.
Other features should also be observed for a chemical agent to be considered effective, such
as lack of toxicity, not to be allergenic, have clinical evidence of significant reductions of pla‐
que and gingivitis, be selective and have specificity to act on pathogenic microbiota, provide
a pleasant taste have to be affordable and easy to use (Van Der Ouderra [51] 1991).
Chemical control of biofilm can be made to prophylactic or therapeutic. In the first case, the
goal would be that there were an imbalance in the microbiota, when mechanical methods
are ineffective. In the therapeutic sense with respect to individuals who already have
changes in order to achieve the predominant bacteria-related diseases, aiming at restoring
the microbiota and its harmony with the host (Marsh [52] 1992).
In 1954, Davies et al. [53] synthesized in the laboratory substance large bacterial action
against Gram + and Gram -, and fungi. From this time, the chlorhexidine is now used as a
general disinfectant for the treatment of various infections.
It was marketed in the 60s, by Imperial Chemical Industries (England), and one of the first
applications of chlorhexidine in dentistry to control biofilm was performed by Schiott and
Löe [54] (1970). The authors recommend the use of 10 mL of chlorhexidine digluconate 0.2%
twice a day for one minute in order to prevent the accumulation of plaque and gingivitis
subsequent. Since then, this compound has been considered the most effective agent in the
chemical control dental biofilm (Souza, Abreu [55] 2003).
Down Syndrome72
Figure 7. Structural formula chlorhexidine
Chlorhexidine is a cationic agent, a bis-guanidine non-toxic molecule is a symmetrical, with
two rings and two 4-chlorophenyl groups ethane pentânicos connected by a central hexam‐
ethylene chain. Is prepared in the form of various salts, and gluconate, the digluconate or
chlorhexidine acetate in its composition (Vinholis et al. [56] 1996). The chlorhexidine digluc‐
onate salt is one of the most widely used in the preparation of therapeutic formulations, be‐
cause of its greater solubility in water and physiological pH, dissociates releasing the active
component (Bonacorsi et al. [57] 2000).
The main site of action of chlorhexidine, both in prokaryotes and in eukaryotic cells is the
cytoplasmic membrane. The mechanism of action of chlorhexidine begins with a call in the
bacterial cell wall, when the adsorption of positive charges in the molecule of the substance
to the surface of the negative charges increases the permeability of the bacterial cell walls of
microorganism and allows the agent to penetrate the cytoplasmic occurring disruption of
cell membrane leakage of intracellular components and low molecular weight, as potassium
ions. At this stage the bacteriostatic effect is considered and reversible. While in high con‐
centrations, lead to enzyme inhibition (ATPase), extravasation of macromolecules (nucleoti‐
des) and clotting components of the cytoplasm, due to the interaction of chlorhexidine with
cytoplasmic proteins and nucleic acid, thus reaching the stage of bactericidal and irreversi‐
ble (Bonacorsi et al. [57] 2000).
The chlorhexidine is usually effective against Gram positive and Gram-negative bacteria,
fungi, yeasts and Candida albicans. It has broad spectrum antibacterial, high substantivity,
is safe and effective (Quagliato [58] 1991).
Second Vinholis et al. [56] (1996), there are three mechanisms for chlorhexidine inhibition of
biofilm:
Chlorhexidine is connected by means of electrostatic forces to the groups of acidic proteins
such as phosphates, sulphates and carboxyl ions found in saliva and mouth tissues, there
avoiding the formation of the acquired pellicle.
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The ability of bacteria to bind to the tooth can be reduced by the absorption of chlorhexidine
to the capsule of extracellular polysaccharides.
Chlorhexidine can compete with Ca + + ions. The mechanism is probably due to a direct
competition between ions and / or availability of the drug and the carboxylic groups in the
oral tissues. Can also inhibit the formation of bridges between the Ca + bacteria and surfa‐
ces, and the bacteria together. Due to its cationic properties, chlorhexidine can bind to the
hydroxyapatite of enamel, and the acquired pellicle salivary proteins (Gjermo 59 1989).
5. Dentifrices with chlorhexidine
The chemical agent chlorhexidine as deputy in the control of dental biofilm is useful in sit‐
uations where oral hygiene is inefficient, is compromised or is impossible to be realized.
This antimicrobial agent is particularly suited to individuals who, because of physical or
mental limitations, they are incapable, in whole or in part, the appropriate mechanical re‐
moval of plaque, were considered patients with special needs (Al-Tannir, Goodman [60]
1994).
That the dentifrices are used in conjunction with toothbrushing, causes the addition of chlo‐
rhexidine greater deserves attention, since it does not represent changes to the patient, as is
routine in the same. Importantly, most studies of dentifrices containing chlorhexidine has
been made with experimental formulations (Sathler, Fischer [61] 1996).
Experimental studies have shown that dentifrices with 0.5% chlorhexidine were less effec‐
tive than rinsing mouthwash with 0.2% chlorhexidine (Addy et al. [62] 1989, Jenkins et al.
[63] 1990). In a study by Gjermo and Rolla [64] (1970), the use of dentifrices with 0.6% chlo‐
rhexidine and 0.8% applied in trays on the teeth to avoid interference from the mechanical
action of toothbrushing, showed a reduction in the rate of plate, and these results were con‐
sistent with those obtained with mouthwash.
Second Jenkins et al. [42] (1993), introduction of 1% chlorhexidine dentifrices promoted to
an improvement in gingival index and plaque index, similar to those experienced in rinsing
with 0.2% chlorhexidine. The authors also state that the association of fluoride with chlo‐
rhexidine dentifrices does not inhibit chlorhexidine.
The use of chlorhexidine dentifrice is a controversial subject. Some research on the short-
term clinical effect of reducing plaque and gingival show the effectiveness of this substance
(Torres 65 2000). This was proved in the study of Storhaug 46 (1977), which evaluated the
use of toothpaste containing 0.8% chlorhexidine in 27 patients with special needs, from 4 to
12 years in a clinic held by the government of Norway. These patients were selected to test
the effects of toothbrushing performed with the plaque index, gingival index, according to
the criteria proposed by Löe and Silness. Patients were then divided into two groups: 17
children were using toothpaste containing chlorhexidine (GI) and 10 children used a placebo
dentifrice (GII). After 6 weeks of study, there was significant reduction in plaque index of
the group that used chlorhexidine compared with the control group and gingival index, no
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significant differences for the group that used chlorhexidine. However, clinically, the acute
signs of inflammation are gone. The author stated that the conventional techniques of oral
hygiene can be difficult to implement for this group of patients and chlorhexidine, in its var‐
ious forms of application, an agent is extremely useful for maintaining oral health of pa‐
tients with special needs.
Russell and Bay [44] (1981) observed that the use of toothpaste the basis of 1% chlorhexidine
in daily brushing of children with epilepsy and mental retardation, reflected in a significant
improvement in plaque and gingival index in this group of patients.
Dolles and Gjermo [41] (1980) evaluated the effect of three dentifrices in reducing dental ca‐
ries and gingivitis (DI - dentifrice containing chlorhexidine (2%), IBD - with fluoride tooth‐
paste (0.1% NaF) and DIII - chlorhexidine dentifrice with the two % and fluorine (0.1% NaF)
for two years. Ninety-one students from 13 to 15 years of age participated in the research.
the group using the dentifrice with fluoride and chlorhexidine showed a lower rate of dental
caries, although the gingival conditions improved in the three groups, showing no statistical
differences.
In a study of experimental gingivitis, Jenkins et al. 42 (1993), found that a dentifrice formula‐
tion of 1% chlorhexidine and 1000 ppm F (NaF) produced statistically significant reductions
in plaque and gingivitis, compared with the placebo dentifrice. Subsequently, Yates et al. 47
1993, proposed to assess the clinical effects of chlorhexidine dentifrice 1%, with or without
the 1000ppmF (NaF) previously tested by Jenkins et al. 42 1993. This study aimed to evalu‐
ate the control of plaque and gingivitis using: a) dentifrice containing 1% chlorhexidine
called single asset, b) 1% of dentifrice containing fluoride clorexidina/1000ppm called active
double c) negative control for six months. The sample consisted of two hundred ninety-sev‐
en individuals aged between 18 and 61 years. The periodontal parameters used were the
plaque index, gingival bleeding and staining that were recorded at the beginning, six, 0,24
weeks, along with the index calculation was also recorded in the sixth, twelfth and twenty-
fourth week. After prophylaxis performed at baseline, the subjects used the assigned denti‐
frice twice a day for one minute, without any other additional information on oral hygiene
were given, just the direction we should use enough toothpaste to cover the head of the
toothbrush. It was not permitted to use any other adjunctive oral hygiene product. At the
end of the study all subjects were examined by a hygienist and extrinsic staining, supragin‐
gival plaque and calculus were removed. The results showed reduction of plaque index and
bleeding in all groups, but a significant improvement occurred in the chlorhexidine group.
In contrast to these results, staining and calculus indices were more significant in the test
groups compared with the control group. The authors concluded that the side effects of
chlorhexidine are acceptable, the dentifrice containing chlorhexidine can be recommended
for the same clinical applications than the other products based on chlorhexidine. The com‐
patibility of fluoride with chlorhexidine in one of the products could be effective in prevent‐
ing tooth decay, and fluoride dentifrice containing chlorhexidine and could provide benefits
to gingival health than preventive and therapeutic applications in clinical dentistry.
The action of a dentifrice containing 1% chlorhexidine in reducing dental plaque and gingi‐
val bleeding in 156 children over a period of twelve weeks, residents in Ga-Rankuwa (Preto‐
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ria, South Africa), aged between 12 and 14 years were evaluated by Gugushe et al. [2] (1994).
The children were divided into three groups, which used conventional dentifrice (group A -
51 subjects), placebo dentifrice (group B - 49 individuals) and chlorhexidine dentifrice
(group C - 56 individuals). Before starting the experiment, they were instructed on oral hy‐
giene, had their records of plaque index, gingival taken and received professional dental
prophylaxis. The record of the indices was repeated in the sixth and twelfth weeks. All pa‐
tients were instructed to make tooth brushing morning and night. In the presence of plaque,
it was observed that the rate decreased in all groups, with reductions substantially equal
groups A and B and further reduction to the group C In relation to the gingival index, a re‐
duction very similar in all groups (approximately 4%) without significant differences. How‐
ever, the dentifrice with 1% chlorhexidine was more effective in controlling dental plaque as
compared with the conventional dentifrice and placebo.
In a clinical study by Sanz et al. [45] (1994), the experimental dentifrice containing chlorhexi‐
dine 0.4% and 0.345 mg of zinc, contributed significantly to the improvement of oral hy‐
giene, both in relation to the plaque and gingivitis and bleeding, resulting in fewer spots
than those found in the group who used mouthwash with chlorhexidine 0.12%. The investi‐
gators concluded that the tested dentifrice can be viewed as a promising alternative for the
use of substances effective in reducing plaque and gingivitis, and offer minimal side effects.
In respect the effect on the microflora of the mouth, the dentifrices to 1% chlorhexidine and
tested for a period of 6 months, promoted reduction of aerobic microorganisms and aneróbi‐
cos (Maynard et al. [66] 1993).
Considering the fact that toothbrushing with dentifrice is the most common habits of oral
hygiene (Owens et al. [12] 1997), this practice can be seen as a plausible way for the intro‐
duction of chemicals to improve the oral health (Yates et al. [47] 1993).
According to Newman [67] (1986), the introduction of antimicrobial agents in dentifrices
aims to improve the effectiveness of toothbrushing, promoting a positive effect in reducing
biofilm.
Thus, Teltelbaum et al. [68,69] (2009, 2010) conducted a study with patients with SD, where
he developed a dentifrice containing these two substances, chlorhexidine and erythrosine
and evaluated the mechanical and chemical control of dental biofilm. The mechanical and
chemical control of dental biofilm in patients with Down syndrome, of using different ex‐
perimental dentifrices in forty institutionalized children between ages 7 and 13 years in the
mixed dentition in an experimental cross-over, blind clinical trial where we used the follow‐
ing protocols: fluoridated dentifrice (protocol G1); fluoridated dentifrice + chlorhexidine
(protocol G2); fluoridated dentifrice + chlorhexidine + plaquedisclosing agent (protocol G3);
and fluoridated dentifrice + plaque-disclosing agent (protocol G4). Each experimental stage
lasted 10 days with a 15-day washout. The evaluated parameters were plaque index and
gingival bleeding and initial clinical conditions between each stage were similar. The denti‐
frices containing plaque-disclosing agent, irrespective of their association with chlorhexi‐
dine, produced a greater reduction in the final plaque index. As for gingival bleeding, the
dentifrice containing erythrosine and the one containing chlorhexidine produced similar re‐
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sults. The dentifrice containing an association of chlorhexidine and erythrosine gave the best
results. Thus, with the methodology employed, it was possible to conclude that the combi‐
nation of drugs (chlorhexidine, fluorine and erythrosine) within one dentifrice can be useful
in controlling dental biofilm and in the reduction of gingival bleeding [68,69].
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